Jump to content
RemedySpot.com

Inherited Form Of Leukemia & Medicare Plan D

Rate this topic


Guest guest

Recommended Posts

Guest guest

Genetic Test Identifies People At High Risk For Developing Inherited Form Of

Leukemia:

" BloodCenter of Wisconsin's Diagnostic Laboratories announced that it is the

first laboratory in the United States to develop and offer a genetic test, known

as " CEBPA Mutation Analysis, " for inherited acute myeloid leukemia (AML). AML is

the second most common form of leukemia. The link between inherited variants in

the CEBPA gene and the familial form of acute myeloid leukemia (AML) was first

described in the New England Journal of Medicine in 2004. This relationship has

subsequently been confirmed in several published reports. Almost all patients

found to have inherited CEBPA mutations have had leukemia. Therefore, germline

CEBPA mutations appear to predict the development of leukemia in individuals who

lack manifestations of the disease.

" Family members of an AML patient who carries an inherited CEBPA mutation can be

tested for the presence of this mutation with BloodCenter's new DNA-based test.

Those in whom the CEBPA mutation is detected can be monitored by their

physicians for signs and symptoms of leukemia. Earlier detection of the cancer

in these patients could result in more rapid treatment, and potentially produce

better outcomes. AML patients and their relatives can also utilize this

information in family planning decisions. "

More of this article can be found at this website:

http://www.medicalnewstoday.com:80/articles/155017.php

__________________________________

MEDICARE COVERAGE GAP:

" The American Psychiatric Association (APA) commended the Senate Finance

Committee, the Obama administration and the nation's pharmaceutical companies

today for addressing the Medicare coverage gap in prescription drug plans for

America's seniors. The coverage gap, known as the Medicare " doughnut hole, "

excludes coverage for the annual costs of prescription medications that exceed

$2,700 but don't reach $6,154, a gap that APA president Alan Schatzberg called

" an excessive burden to those over 65 and those who are chronically disabled,

including those suffering from mental illnesses. "

" Under the new agreement on the part of Congress and PhRMA, the largest

organization representing the pharmaceutical industry, drug companies will

provide $80 billion to cover up to 50 percent of the cost of brand-name

medications that fall through the gap in Medicare's Part D prescription program.

The agreement is being discussed as part of the major health care reform

legislation being considered by Congress.

" Although this is a first step, it is a step in the direction of providing

high-quality, affordable health care to all Americans, " Dr. Schatzberg said.

" The APA recognizes that full prescription coverage is an integral part of any

meaningful health care reform and applauds the effort to eliminate one of the

most glaring deficiencies in Medicare. "

" We hope to see this agreement take effect as part of a package that includes

the comprehensive and universal health care coverage that the American people

need and deserve, " Dr. Schatzberg said.

Source

American Psychiatric Association

http://www.medicalnewstoday.com:80/articles/155460.php

___________________________

FYI,

Lottie

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...